热门资讯> 正文

VistaGen任命Nick Tressler为首席财务官

2025-12-01 21:45

Vistagen (VTGN) on Monday announced the appointment of Nick Tressler as Chief Financial Officer (CFO), effective December 1, 2025.
Most recently, he served as CFO of DYNEX Technologies, and before that, he was the CFO at American Gene Technologies International and Senseonics Holdings, Inc. (SENS).

More on VistaGen Therapeutics

Vistagen Therapeutics: Intranasal Pherines And A Make-Or-Break 2026
Vistagen Therapeutics, Inc. (VTGN) Q2 2026 Earnings Call Transcript
Vistagen targets NDA submission for fasedienol in mid-2026 as PALISADE-3 study nears data readout
Seeking Alpha’s Quant Rating on VistaGen Therapeutics
Historical earnings data for VistaGen Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。